Skip to main content

Table 2 In vitro cytotoxicity assay in CDDP-sensitive and -resistant gastric cancer cell lines

From: Anti-cancer effects of newly developed chemotherapeutic agent, glycoconjugated palladium (II) complex, against cisplatin-resistant gastric cancer cells

MKN28

Resistance factor

IC50(μM)

  

MKN28(0)

MKN28(CDDP)

[PdCl2(L)]

1.02

78.9 ± 4.0

80.8 ± 6.6

L-OHP

1.19

46.4 ± 4.0

55.2 ± 3.8

[PtCl2(L)]

2.54

111.7 ± 27.1

283.9 ± 19.3

CDDP

3.37

19.4 ± 2.4

65.4 ± 4.6

CABDA

4.33

202.9 ± 17.2

878.3 ± 34.1

MKN45

Resistance factor

IC50(μM)

  

MKN45(0)

MKN45(CDDP)

[PdCl2(L)]

1.14

61.2 ± 6.8

69.7 ± 4.1

L-OHP

1.3

27.3 ± 1.1

35.6 ± 6.7

[PtCl2(L)]

2.18

129.5 ± 14.8

282.6 ± 34.5

CDDP

3.27

23.5 ± 2.2

77.0 ± 8.5

CABDA

3.42

152.8 ± 3.7

522.0 ± 27.4